During the recent high-level event “Cardiovascular Prevention as the Cornerstone of a Competitive Europe – Scaling Up Lipid Screening to Secure Next Generations,” which took place at the European Parliament on 25 September 2025, FH-EARLY’s coordinator Prof. @faustojcapinto highlighted the power of collaboration in driving innovation. He reminded us that real innovation in FH care starts with collaboration.
From chip arrays to AI tools and patient-led panels, FH-EARLY is building solutions with patients, not just for them. Together, we’re turning research into action — and advocacy into impact.
Because prevention is not just possible — it’s personal.
Innovation Driving Change
A session dedicated to innovation showcased how EU-funded projects – PERFECTO, PerMed FH and FH-EARLY – are combining genetics, artificial intelligence, behavioural science and patient co-design to close detection gaps and deliver practical, scalable models of care.
In a video address, Professor Fausto Pinto of Portugal, coordinator of FH-EARLY, underscored that “Innovation is not abstract. It is concrete, collaborative and actionable.” These projects are already influencing national activities and screening policies in Romania, Cyprus and Bulgaria, proving that European collaboration can translate scientific advances into tangible benefits for patients. Furthermore, they provide clear innovative and scalable solutions addressing personalised communication as presented by Dr Marius Geanta, founder and President of InoMed, cheaper and faster genetic testing which will improve personalised prevention by offering precise diagnosis and personalised management protocols as highlighted by Professor Mafalda Bourbon from Portugal, coordinator of PerMed FH consortium and the mastermind behind FH-EARLY’s chip array solution. And the proofs are already visible, for example in Cyprus, where FH screening is being enhanced by implementing the personalised communication model as explained by Prof Andrie Panayiotou, President of the Cypriot Atherosclerosis Society and partner in PERFECTO FH consortium.
All credits: FH Europe Foundation
